Literature DB >> 2251539

Pheochromocytoma and acute myocardial infarction.

J G Nirgiotis1, R J Andrassy.   

Abstract

When a pheochromocytoma is manifested as an acute myocardial illness, diagnosis may be difficult to make. If the tumor is suspected early enough, a workup can be done while the complications of the myocardial illness are being controlled (as in our case). The tumor can then be expeditiously removed before any further problems develop. The case presented here underscores the importance of maintaining a high index of suspicion for a pheochromocytoma in any patient who has an unexpected myocardial event.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251539     DOI: 10.1097/00007611-199012000-00027

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  [Cardiogenic shock in a 61 year old female with recurrent panic attacks].

Authors:  K Mischke; J Graf; D Rulands; K C Koch; P Hanrath; U Janssens
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

2.  Pheochromocytoma crisis presenting with cardiogenic shock.

Authors:  Y S Chatzizisis; A Ziakas; C Feloukidis; D Paramythiotis; S Hadjimiltiades; A Iliadis; G Basdanis; I Styliadis
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

Review 3.  Pheochromocytoma-induced myocardial infarction in pregnancy. A case report and literature review.

Authors:  C R Jessurun; K Adam; K J Moise; S Wilansky
Journal:  Tex Heart Inst J       Date:  1993

Review 4.  Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome.

Authors:  Shams Y-Hassan; Henrik Falhammar
Journal:  Endocrine       Date:  2019-08-09       Impact factor: 3.633

5.  Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in pheochromocytoma.

Authors:  Il-Woo Suh; Cheol Whan Lee; Young-Hak Kim; Myeong-Ki Hong; Jae-Won Lee; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.